Clinical Trial Update: Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy, HLX07and Serplulimab in LARC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating short-course radiotherapy followed by neoadjuvant chemotherapy with HLX07 and serplulimab in locally advanced rectal cancer; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• HLX07 (HLX07)
• Serplulimab (serplulimab)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Rectal Cancer | Phase 2 | Status: RECRUITING